SLC10A3
gene geneOn this page
Also known as P3DXS253E
Summary
SLC10A3 (solute carrier family 10 member 3, HGNC:22979) is a protein-coding gene on chromosome Xq28, encoding P3 protein (P09131). The ubiquitous expression and the conservation of the sequence in distant animal species suggest that the gene codes for a protein with housekeeping functions.
This gene maps to a GC-rich region of the X chromosome and was identified by its proximity to a CpG island. It is thought to be a housekeeping gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
Source: NCBI Gene 8273 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 73 total
- MANE Select transcript:
NM_019848
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22979 |
| Approved symbol | SLC10A3 |
| Name | solute carrier family 10 member 3 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | P3, DXS253E |
| Ensembl gene | ENSG00000126903 |
| Ensembl biotype | protein_coding |
| OMIM | 312090 |
| Entrez | 8273 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 protein_coding
ENST00000263512, ENST00000369649, ENST00000393586, ENST00000393587, ENST00000453912, ENST00000651600, ENST00000882890, ENST00000882891, ENST00000882892, ENST00000882893, ENST00000882894, ENST00000882895, ENST00000922672, ENST00000922673, ENST00000922674
RefSeq mRNA: 3 — MANE Select: NM_019848
NM_001142391, NM_001142392, NM_019848
CCDS: CCDS14755, CCDS48195
Canonical transcript exons
ENST00000651600 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003841872 | 154490307 | 154490629 |
| ENSE00003843615 | 154487311 | 154489082 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 91.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.4910 / max 267.7466, expressed in 1813 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201036 | 30.7797 | 1806 |
| 201037 | 8.7113 | 1772 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right coronary artery | UBERON:0001625 | 91.44 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 91.41 | gold quality |
| skin of leg | UBERON:0001511 | 91.38 | gold quality |
| thoracic aorta | UBERON:0001515 | 91.30 | gold quality |
| ascending aorta | UBERON:0001496 | 91.25 | gold quality |
| stromal cell of endometrium | CL:0002255 | 91.13 | gold quality |
| right ovary | UBERON:0002118 | 91.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.60 | gold quality |
| aorta | UBERON:0000947 | 90.52 | gold quality |
| granulocyte | CL:0000094 | 90.42 | gold quality |
| decidua | UBERON:0002450 | 90.29 | gold quality |
| skin of abdomen | UBERON:0001416 | 90.27 | gold quality |
| left ovary | UBERON:0002119 | 90.25 | gold quality |
| popliteal artery | UBERON:0002250 | 90.09 | gold quality |
| tibial artery | UBERON:0007610 | 90.08 | gold quality |
| left coronary artery | UBERON:0001626 | 89.78 | gold quality |
| left uterine tube | UBERON:0001303 | 89.77 | gold quality |
| gingival epithelium | UBERON:0001949 | 89.70 | gold quality |
| apex of heart | UBERON:0002098 | 89.36 | gold quality |
| zone of skin | UBERON:0000014 | 89.28 | gold quality |
| coronary artery | UBERON:0001621 | 89.25 | gold quality |
| gingiva | UBERON:0001828 | 89.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 89.08 | gold quality |
| ectocervix | UBERON:0012249 | 89.05 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.91 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 88.80 | gold quality |
| gall bladder | UBERON:0002110 | 88.69 | gold quality |
| body of uterus | UBERON:0009853 | 88.60 | gold quality |
| esophagus | UBERON:0001043 | 88.36 | gold quality |
| endocervix | UBERON:0000458 | 88.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.95 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
38 targeting SLC10A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-6878-3P | 99.24 | 64.23 | 920 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-6797-3P | 99.17 | 66.94 | 668 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-1909-5P | 98.94 | 64.01 | 484 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-6076 | 98.61 | 65.69 | 637 |
| HSA-MIR-4303 | 98.01 | 68.13 | 2304 |
| HSA-MIR-876-5P | 97.99 | 68.49 | 1345 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc10a3 | ENSDARG00000103220 |
| mus_musculus | Slc10a3 | ENSMUSG00000032806 |
| rattus_norvegicus | Slc10a3 | ENSRNOG00000060580 |
| drosophila_melanogaster | CG11655 | FBGN0030638 |
| drosophila_melanogaster | CG9903 | FBGN0030756 |
| caenorhabditis_elegans | WBGENE00044650 |
Paralogs (5): SLC10A1 (ENSG00000100652), SLC10A2 (ENSG00000125255), SLC10A4 (ENSG00000145248), SLC10A6 (ENSG00000145283), SLC10A5 (ENSG00000253598)
Protein
Protein identifiers
P3 protein — P09131 (reviewed: P09131)
Alternative names: Solute carrier family 10 member 3
All UniProt accessions (3): P09131, A0A0A0MS43, Q5HY78
UniProt curated annotations — full annotation on UniProt →
Function. The ubiquitous expression and the conservation of the sequence in distant animal species suggest that the gene codes for a protein with housekeeping functions.
Subcellular location. Membrane.
Similarity. Belongs to the bile acid:sodium symporter (BASS) (TC 2.A.28) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P09131-1 | 1 | yes |
| P09131-2 | 2 |
RefSeq proteins (3): NP_001135863, NP_001135864, NP_062822* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002657 | BilAc:Na_symport/Acr3 | Family |
| IPR004710 | Bilac:Na_transpt | Family |
| IPR038770 | Na+/solute_symporter_sf | Homologous_superfamily |
| IPR057103 | NTCP5_P3_N | Domain |
Pfam: PF01758, PF24690
UniProt features (12 total): transmembrane region 8, chain 1, splice variant 1, sequence variant 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P09131-F1 | 77.41 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 133 (showing top):
CTATGCA_MIR153, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT, GOBP_RESPONSE_TO_LIPID, GOBP_MONOCARBOXYLIC_ACID_TRANSPORT, GOBP_RESPONSE_TO_RETINOIC_ACID, LIU_CMYB_TARGETS_UP, KIM_WT1_TARGETS_12HR_UP, GOBP_LIPID_LOCALIZATION, MILI_PSEUDOPODIA_CHEMOTAXIS_DN, GOBP_TRANSMEMBRANE_TRANSPORT
GO Biological Process (3): bile acid and bile salt transport (GO:0015721), response to retinoic acid (GO:0032526), transmembrane transport (GO:0055085)
GO Molecular Function (2): bile acid:sodium symporter activity (GO:0008508), symporter activity (GO:0015293)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lipid transport | 1 |
| monocarboxylic acid transport | 1 |
| organic hydroxy compound transport | 1 |
| response to lipid | 1 |
| response to oxygen-containing compound | 1 |
| transport | 1 |
| cellular process | 1 |
| organic acid:sodium symporter activity | 1 |
| bile acid transmembrane transporter activity | 1 |
| secondary active monocarboxylate transmembrane transporter activity | 1 |
| secondary active transmembrane transporter activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
648 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC10A3 | SLC12A1 | Q13621 | 776 |
| SLC10A3 | SLC10A7 | Q0GE19 | 753 |
| SLC10A3 | GOLPH3 | Q9H4A6 | 602 |
| SLC10A3 | SLC12A2 | P55011 | 528 |
| SLC10A3 | VMA12 | Q8N511 | 477 |
| SLC10A3 | SLC12A3 | P55017 | 402 |
| SLC10A3 | UBL4A | P11441 | 369 |
| SLC10A3 | RTL5 | Q5HYW3 | 347 |
| SLC10A3 | TTC16 | Q8NEE8 | 341 |
| SLC10A3 | TEX261 | Q6UWH6 | 338 |
| SLC10A3 | OCA2 | Q04671 | 329 |
| SLC10A3 | SLC35B3 | Q9H1N7 | 327 |
| SLC10A3 | FBN1 | P35555 | 304 |
| SLC10A3 | SLC10A2 | Q12908 | 301 |
| SLC10A3 | SLC10A1 | Q14973 | 298 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SORBS1 | SLC10A3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SLC10A3 | CPD | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (22): SLC10A3 (Affinity Capture-RNA), SLC10A3 (Affinity Capture-RNA), SLC10A3 (Affinity Capture-RNA), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), SLC10A3 (Co-fractionation), TVP23B (Co-fractionation), YIPF1 (Co-fractionation), YIPF2 (Co-fractionation), YIPF6 (Co-fractionation), ACTG1 (Affinity Capture-MS)
ESM2 similar proteins: A0AV02, A2AWR3, A2VCW5, A4QN56, A6QP84, B2RXV4, D4A7H1, F7B113, G8XYX6, O08705, O70324, P09131, P19634, P21129, P23791, P26431, P26434, P26435, P36021, P48761, P48762, P97751, Q0V8N6, Q14973, Q28036, Q3KNW5, Q3UEZ8, Q4JLT5, Q5PT54, Q5PT56, Q5R9A7, Q61165, Q70EX6, Q71RS6, Q7Z3F1, Q8BFW9, Q8BLV3, Q8BUE1, Q8BZ00, Q8C261
Diamond homologs: A6QP84, O08705, P09131, P26435, P70172, Q12908, Q14973, Q28727, Q3KNW5, Q3UEZ8, Q4JLT5, Q5PT55, Q5PT56, Q60414, Q62633, Q70EX6, Q7XVB3, Q96EP9, Q9CXB2, B8BDK4, F4JPW1, O34524, P21129, Q1EBV7, Q5PT54, Q5VRB2, Q650U0, Q6K739, Q8RXE8, Q8VYY4, Q8ZKL0, Q93YR2, Q0V8N6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
73 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 8 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
501 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:154489081:CC:C | acceptor_gain | 0.9900 |
| X:154489082:CC:C | acceptor_gain | 0.9900 |
| X:154489083:C:CC | acceptor_gain | 0.9900 |
| X:154489091:G:GC | acceptor_gain | 0.9900 |
| X:154489078:TGTCC:T | acceptor_gain | 0.9800 |
| X:154489083:C:CA | acceptor_loss | 0.9800 |
| X:154489083:C:T | acceptor_gain | 0.9800 |
| X:154489084:T:A | acceptor_loss | 0.9800 |
| X:154489091:G:C | acceptor_gain | 0.9800 |
| X:154489999:A:T | acceptor_gain | 0.9800 |
| X:154489080:TCC:T | acceptor_gain | 0.9700 |
| X:154489081:CCC:C | acceptor_gain | 0.9700 |
| X:154490301:CCCTA:C | donor_loss | 0.9700 |
| X:154490302:CCTA:C | donor_loss | 0.9700 |
| X:154490303:CTA:C | donor_loss | 0.9700 |
| X:154490304:TA:T | donor_loss | 0.9700 |
| X:154490305:A:AT | donor_loss | 0.9700 |
| X:154490306:CCT:C | donor_loss | 0.9700 |
| X:154488947:T:TA | donor_gain | 0.9600 |
| X:154489998:C:CT | acceptor_gain | 0.9600 |
| X:154489079:GTCC:G | acceptor_gain | 0.9500 |
| X:154490618:G:C | donor_gain | 0.9500 |
| X:154489730:G:A | donor_gain | 0.9300 |
| X:154490058:C:CT | acceptor_gain | 0.9000 |
| X:154490508:C:A | donor_gain | 0.9000 |
| X:154489713:CA:C | donor_gain | 0.8900 |
| X:154490587:CTCT:C | donor_loss | 0.8900 |
| X:154490588:TCTCA:T | donor_loss | 0.8900 |
| X:154490589:CTCA:C | donor_loss | 0.8900 |
| X:154490590:TCA:T | donor_loss | 0.8900 |
AlphaMissense
3056 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:154487864:G:C | S359R | 0.996 |
| X:154487864:G:T | S359R | 0.996 |
| X:154487866:T:G | S359R | 0.996 |
| X:154488119:G:C | S274R | 0.995 |
| X:154488119:G:T | S274R | 0.995 |
| X:154488121:T:G | S274R | 0.995 |
| X:154487687:G:C | S418R | 0.994 |
| X:154487687:G:T | S418R | 0.994 |
| X:154487689:T:G | S418R | 0.994 |
| X:154487943:G:C | P333R | 0.994 |
| X:154487663:G:C | S426R | 0.993 |
| X:154487663:G:T | S426R | 0.993 |
| X:154487665:T:G | S426R | 0.993 |
| X:154487666:G:C | N425K | 0.993 |
| X:154487666:G:T | N425K | 0.993 |
| X:154487691:A:T | V417D | 0.993 |
| X:154488168:A:G | L258P | 0.993 |
| X:154488172:C:G | G257R | 0.993 |
| X:154488318:C:T | G208E | 0.993 |
| X:154488328:A:G | C205R | 0.993 |
| X:154487943:G:T | P333H | 0.992 |
| X:154488171:C:T | G257D | 0.991 |
| X:154487605:A:G | S446P | 0.988 |
| X:154487931:C:T | G337D | 0.988 |
| X:154488707:A:C | F78L | 0.988 |
| X:154488707:A:T | F78L | 0.988 |
| X:154488709:A:G | F78L | 0.988 |
| X:154488157:A:G | C262R | 0.986 |
| X:154488708:A:C | F78C | 0.986 |
| X:154488057:G:T | A295D | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000882856 (X:154487666 G>A), RS1001532201 (X:154492412 G>A,T), RS1001759527 (X:154491944 C>T), RS1003194654 (X:154490729 C>T), RS1003245410 (X:154491006 C>T), RS1003433708 (X:154490433 G>A,C), RS1004059292 (X:154490741 C>A), RS1004514309 (X:154491054 T>C), RS1005779722 (X:154489346 G>A), RS1008236188 (X:154491571 T>G), RS1010576976 (X:154490327 G>A), RS1011999814 (X:154491875 C>A,T), RS1015067015 (X:154492503 G>A), RS1016838133 (X:154491068 G>C), RS1017141046 (X:154490748 G>A,C)
Disease associations
OMIM: gene MIM:312090 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC10 family of sodium-bile acid co-transporters
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| cupric chloride | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| ICG 001 | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Zidovudine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4HF | HCT116-SLC10A3-KO-c2 | Cancer cell line | Male |
| CVCL_D4HG | HCT116-SLC10A3-KO-c6 | Cancer cell line | Male |
| CVCL_TL41 | HAP1 SLC10A3 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.